Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of the Rivaroxaban and macitentan inducer St. John's Wort (SJW) on the pharmacokinetics of these drugs in healthy volunteers

Trial Profile

Effect of the Rivaroxaban and macitentan inducer St. John's Wort (SJW) on the pharmacokinetics of these drugs in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2018

At a glance

  • Drugs Macitentan (Primary) ; Rivaroxaban (Primary)
  • Indications Atrial fibrillation
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Sep 2018 New trial record
    • 07 Sep 2018 Results published in the British Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top